Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovate (VATE) Asset Writedowns and Impairment (2016 - 2024)

Innovate (VATE) has 15 years of Asset Writedowns and Impairment data on record, last reported at $100000.0 in Q4 2024.

  • For Q4 2024, Asset Writedowns and Impairment fell 91.67% year-over-year to $100000.0; the TTM value through Dec 2024 reached $1.9 million, up 5.56%, while the annual FY2024 figure was $100000.0, 94.44% down from the prior year.
  • Asset Writedowns and Impairment reached $100000.0 in Q4 2024 per VATE's latest filing, down from $1.2 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $11.1 million in Q3 2020 and bottomed at $100000.0 in Q1 2020.
  • Average Asset Writedowns and Impairment over 5 years is $1.4 million, with a median of $100000.0 recorded in 2020.
  • The widest YoY moves for Asset Writedowns and Impairment: up 2000.0% in 2021, down 96.0% in 2021.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $2.5 million in 2020, then plummeted by 96.0% to $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022, then skyrocketed by 1100.0% to $1.2 million in 2023, then tumbled by 91.67% to $100000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Asset Writedowns and Impairment were $100000.0 in Q4 2024, $1.2 million in Q4 2023, and $500000.0 in Q3 2023.